DK1326599T3 - Anvendelse af aivlosin til behandling eller forebyggelse af Lawsonia-infektioner i grise - Google Patents

Anvendelse af aivlosin til behandling eller forebyggelse af Lawsonia-infektioner i grise

Info

Publication number
DK1326599T3
DK1326599T3 DK01976452T DK01976452T DK1326599T3 DK 1326599 T3 DK1326599 T3 DK 1326599T3 DK 01976452 T DK01976452 T DK 01976452T DK 01976452 T DK01976452 T DK 01976452T DK 1326599 T3 DK1326599 T3 DK 1326599T3
Authority
DK
Denmark
Prior art keywords
aivlosin
pigs
prevention
treatment
lawsonia infections
Prior art date
Application number
DK01976452T
Other languages
Danish (da)
English (en)
Inventor
Michael John Sanders
Original Assignee
Eco Animal Health Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eco Animal Health Ltd filed Critical Eco Animal Health Ltd
Application granted granted Critical
Publication of DK1326599T3 publication Critical patent/DK1326599T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Medicinal Preparation (AREA)
  • Feed For Specific Animals (AREA)
  • Saccharide Compounds (AREA)
DK01976452T 2000-10-18 2001-10-15 Anvendelse af aivlosin til behandling eller forebyggelse af Lawsonia-infektioner i grise DK1326599T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0025556.2A GB0025556D0 (en) 2000-10-18 2000-10-18 Treatment and prophylaxis of disease and infections of pigs and poultry
PCT/GB2001/004575 WO2002032233A2 (en) 2000-10-18 2001-10-15 Treatment and prophylaxis of diseases and infections of pigs and poultry with aivlosin

Publications (1)

Publication Number Publication Date
DK1326599T3 true DK1326599T3 (da) 2007-04-10

Family

ID=9901546

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01976452T DK1326599T3 (da) 2000-10-18 2001-10-15 Anvendelse af aivlosin til behandling eller forebyggelse af Lawsonia-infektioner i grise

Country Status (20)

Country Link
US (2) US20040082524A1 (de)
EP (1) EP1326599B1 (de)
JP (2) JP4335524B2 (de)
KR (2) KR100866021B1 (de)
CN (6) CN1803141A (de)
AR (2) AR031002A1 (de)
AT (1) ATE347888T1 (de)
AU (1) AU2001295722A1 (de)
BR (4) BRPI0114703B1 (de)
CA (1) CA2425319C (de)
CY (1) CY1107480T1 (de)
DE (1) DE60125212T2 (de)
DK (1) DK1326599T3 (de)
ES (1) ES2278788T3 (de)
GB (1) GB0025556D0 (de)
MX (1) MXPA03003309A (de)
PL (1) PL221310B1 (de)
PT (1) PT1326599E (de)
RU (2) RU2454230C2 (de)
WO (1) WO2002032233A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0315629D0 (en) * 2003-07-03 2003-08-13 Eco Animal Health Ltd New uses for antibiotic
CA2657275C (en) * 2006-07-13 2013-09-24 Eco Animal Health Limited Use of tylvalosin as antiviral agent
GB0613952D0 (en) * 2006-07-13 2006-08-23 Eco Animal Health Ltd Antiviral agent
RU2487709C2 (ru) * 2011-06-01 2013-07-20 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Белгородская государственная сельскохозяйственная академия имени В.Я. Горина" (ФГБОУ БелГСХА им. В.Я. Горина) Композиционный препарат для лечения пневмонии поросят
WO2014175757A1 (ru) * 2013-04-22 2014-10-30 Общество с ограниченной ответственностью "Нанобиотех" Антисептический ветеринарный препарат и способы его использования
CN104127429A (zh) * 2014-07-28 2014-11-05 邳州正康生物技术有限公司 一种用于防治畜禽呼吸道疾病的饮水剂及其制备方法
CN104256168B (zh) * 2014-09-28 2016-05-11 山东新希望六和集团有限公司 一种猪功能性饲料及其制备方法
CN106361707B (zh) * 2016-09-30 2019-02-26 广东温氏大华农生物科技有限公司 一种酒石酸泰万菌素颗粒制剂及其制备方法
CN107625779A (zh) * 2017-10-19 2018-01-26 洛阳瑞华动物保健品有限公司 一种用于抑制猪蓝耳病病毒复制的药物制剂、药剂盒
CN118021765A (zh) * 2024-04-15 2024-05-14 中国农业科学院农业环境与可持续发展研究所 酒石酸泰万菌素纳米制剂及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4201843A (en) * 1975-08-01 1980-05-06 Sanraku Ocean Co., Ltd. Process for manufacturing tylosin derivatives
US4092473A (en) * 1975-08-01 1978-05-30 Sanraku Ocean Co., Ltd. Tylosin derivatives and their manufacturing process
JPS52139088A (en) * 1976-05-15 1977-11-19 Sanraku Inc Antibiotics tyrocin derivatives and their preparation
DK144084A (da) * 1983-03-03 1984-09-04 Lilly Co Eli Makrolid, dets fremstilling og anvendelse
US4559301A (en) * 1983-03-03 1985-12-17 Eli Lilly And Company Process for preparing macrocin derivatives
US4582822A (en) * 1984-10-09 1986-04-15 Eli Lilly And Company Antibiotic A80190, pharmaceutical compositions containing same and method of use
DE3725946A1 (de) * 1987-08-05 1989-02-16 Boehringer Ingelheim Vetmed Stabilisierter futtermittelzusatz und verfahren zu seiner herstellung
SE9801742L (sv) * 1998-05-18 1999-11-19 Akzo Nobel Nv Användning av naturliga substanser innehållande tymol vid framställning av djurfoder
US6326364B1 (en) * 1999-02-08 2001-12-04 Cedars-Sinai Medical Center Use of 5-aminosalicylates as antimicrobial agents

Also Published As

Publication number Publication date
RU2454230C2 (ru) 2012-06-27
US20060247184A1 (en) 2006-11-02
MXPA03003309A (es) 2003-06-19
ES2278788T3 (es) 2007-08-16
BR122013012293B1 (pt) 2016-06-21
PT1326599E (pt) 2007-03-30
EP1326599B1 (de) 2006-12-13
AR031002A1 (es) 2003-09-03
AU2001295722A1 (en) 2002-04-29
RU2007105450A (ru) 2008-08-20
RU2310446C2 (ru) 2007-11-20
BRPI0114703B1 (pt) 2016-07-05
JP2008297316A (ja) 2008-12-11
BR122013012292B1 (pt) 2016-06-21
CN1771980A (zh) 2006-05-17
CN1803142A (zh) 2006-07-19
BR122013012291B1 (pt) 2016-06-21
CN1853644B (zh) 2010-12-08
US20040082524A1 (en) 2004-04-29
KR20090005287A (ko) 2009-01-13
CN1803140A (zh) 2006-07-19
KR100919725B1 (ko) 2009-09-29
JP5001234B2 (ja) 2012-08-15
CN100471501C (zh) 2009-03-25
DE60125212D1 (de) 2007-01-25
AR098251A2 (es) 2016-05-18
WO2002032233A3 (en) 2002-08-01
BR0114703A (pt) 2003-12-23
GB0025556D0 (en) 2000-12-06
DE60125212T2 (de) 2007-11-15
ATE347888T1 (de) 2007-01-15
CN1469742A (zh) 2004-01-21
WO2002032233A2 (en) 2002-04-25
KR20030046491A (ko) 2003-06-12
PL221310B1 (pl) 2016-03-31
PL362085A1 (en) 2004-10-18
CN1803141A (zh) 2006-07-19
KR100866021B1 (ko) 2008-10-31
CA2425319A1 (en) 2002-04-25
JP2004511498A (ja) 2004-04-15
CN1853644A (zh) 2006-11-01
CA2425319C (en) 2010-01-05
EP1326599A2 (de) 2003-07-16
JP4335524B2 (ja) 2009-09-30
CY1107480T1 (el) 2013-03-13

Similar Documents

Publication Publication Date Title
NO2012018I1 (no) Canakinumab eller direkte ekvivalenter derav
ATE473944T1 (de) Mittel zur wasserbehandlung
DE60045394D1 (de) Zusammensetzungen gegen infektionen zur behandlung erkrankten gewebes wie z.b. fieberbläschen
DK1326957T3 (da) Fremgangsmåde til forhindring eller formindskelse af uklarheder i drikkevarer
DE60123389D1 (de) Stabile, wässerige zusammensetzungen zur behandlung von oberflächen , insbesondere geweben
MA26207A1 (fr) Compositions de traitement de l'eau.
DK1337687T3 (da) Systemer og fremgangsmåder til forhindring af og/eller reduktion af korrosion i forskellige emner
DE60120973D1 (de) Hochfeuchtigkeitsperrende folien
DK1250146T3 (da) Anvendelse af botulinumtoxin til behandling af diabetes
IT1318649B1 (it) Composizioni farmaceutiche per il trattamento di mucositi e stomatiti.
DK1278540T3 (da) Anvendelse af IL-18-inhibitorer til behandling og/eller forebyggelsen af aterosklerose
DK1694342T3 (da) Fremgangsmåder til anvendelse af gelsolin til behandling eller forebyggelse af bakteriel sepsis
PT1228028E (pt) Sais de hidroxieicosatetraeniato, composicoes e metodos para utilizacao no tratamento de perturbacoes da secura ocular
DK1326599T3 (da) Anvendelse af aivlosin til behandling eller forebyggelse af Lawsonia-infektioner i grise
ID29506A (id) Masker sekali pakai
NO20025134D0 (no) Anvendelse av azalid-antibiotiske sammensetninger for behandling eller forebygging av bakteriell eller protozo infeksjonhos pattedyr
BR0101691B1 (pt) composições de pelìcula de poliolefina com propriedades de antiembaçamento permanentes e uso das referidas composições.
DE60114039D1 (de) Kautschukzusammensetzungen und vulkanisate einschliesslich verzweigter kammpolymere
DK1411970T3 (da) Anvendelse af SARP-1 til behandling og/eller forebyggelse af sclerodermia
NO20032769D0 (no) Kombinasjonsmetode for behandling av virale infeksjoner
DE60111477D1 (de) Arbeitsplattenbearbeitungssystem
CL2004001006A1 (es) Compuestos derivados de macrolidos de 14 o 15 miembros, sustituidos en posicion 4"; procedimiento para su preparacion; composicion farmaceuticas que lo comprende; y su uso para el tratamiento o profilaxis de infecciones microbianas sistemicas o topic
ES1044076Y (es) Dispositivo para la limpieza de fondos de piscinas.
CL2004001005A1 (es) Compuestos derivados de macrolidos de 15 miembros, sustituidos en posicion 4", procedimiento para su preparacion; composicion farmaceutica que lo comprende; y su uso para el tratamiento o profilaxis de infecciones microbianas sistemicas o topicas.
EE200200423A (et) Rofleponiidi kasutamine ärritunud soole sündroomi(IBS) ravis